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Abstract
The aim of the study was to assess the acute effect of whole-body vibration (WBV) exercise, with low frequency (5 Hz), on the
pain level (PL), trunk flexibility, and cardiovascular responses (blood pressure [BP] and heart rate [HR]) in individuals with
metabolic syndrome (MetS). Forty-four individuals were included in the study (control: 15) or in (WBV exercise: 29) groups. They
were submitted to 3 bouts (1 minute each) of WBV exercise (5 Hz and peak-to-peak displacements of 2.5, 5.0, and 7.5 mm,
corresponding to peak accelerations of 0.12, 0.25, and 0.35 g, respectively, sitting in a chair with the feet on the platform with
knees flexed, followed by 1 minute of interset rest. The Control Group performed the same protocol, but the platform was
turned off. The PL was measured through the visual analog pain scale, and the flexibility was measured through the anterior trunk
flexion test. Significant improvements on PL (P ¼ .031) and flexibility (P ¼ .004) were found only in the WBV exercise group. The
BP and HR remained at physiological levels. In conclusion, the WBV exercise would lead to physiological response decreasing PL
and increasing flexibility as well as maintaining the cardiovascular responses in individuals with MetS.
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Introduction
Metabolic syndrome (MetS) is a clinical disorder defined by
interconnected physiological, biochemical, clinical, and meta-
bolic factors, including alterations in the level of the lipids in
the plasma, arterial hypertension, central adiposity, and insulin
resistance and hyperglycemia that directly increase the cardi-
ovascular risks.1 Moreover, these conditions are linked by a
pathophysiological basis in low-grade chronic inflammation
and also increase the risk of type 2 diabetes mellitus (T2DM)
and all-cause mortality.2
Musculoskeletal pain can be found in individuals with
MetS,3 and they can also show peripheral small-fiber neuro-
pathy, characterized by damage to the primary afferent noci-
ceptors due to chronic hyperglycemia, when the T2DM is
present.2 This damage causes peripheral sensitization, leading
to central neuron hyperexcitability and spontaneous nerve
impulse generation, presenting as chronic pain.2 In addition,
obese people have more pain than normal weight individuals.4
Duruo¨z et al5 have reported that in individuals with MetS, low
back pain can also be found. In general, the mechanisms under-
lying the association between these metabolic disturbances and
pain are not still well known, although the inflammation6 and
the mechanical overload7 seem to have important roles in these
relations.
According to World Health Organization (WHO), in 2016,8
more than 50% of deaths and disability related to cardiovascu-
lar diseases can be eliminated by a combination of national
efforts and individual actions to reduce major risk factors such
as high blood pressure (BP), high cholesterol, obesity, and
smoking. Then, the morbidity and the mortality may be
reduced by simple lifestyle interventions and easily modifiable
behavior changes. The WHO8 estimates that 25% of healthier
life-years will be lost to cardiovascular disease globally by
2020 if no action is taken to improve cardiovascular health and
current trends. Putting together all the considerations, MetS
would be related to a cluster of risk factors for cardiovascular
disease and T2DM, which occur together more often than by
chance alone.9 Heart disease and stroke costs in the United
States were about $320 billion on health care and lost produc-
tivity in 2011 according the Centers for Disease Control and
Prevention.10 In this context, the WHO8 has stated that coun-
tries might adopt policies and programs to promote population-
wide interventions such as encouraging exercise and other
actions. The physical disuse has been presented as one of the
perpetuating factors for chronicity of pain, and some authors11
have suggested that the presence of MetS is importantly asso-
ciated with a low physical performance and decreased cardior-
espiratory endurance, flexibility, and muscular strength.12
Chang et al13 have reported that the presence of MetS was
also associated with a decrease in flexibility in a community-
based geriatric population. Therefore, physical reconditioning
has been proposed in clinical practice as a goal in the treatment
of patients with MetS.14 Despite this, not all forms of exercise
are equally effective and safe; although aerobic exercise1,15 or
resistance training has been associated with decreased
cardiovascular disease risk factors, obesity, or MetS sever-
ity14,16 due to the pain or even the low physical fitness, most
individuals are unable or unwilling to perform these
exercises.11,17
Given the limitations for some types of exercises that many
individuals report, different forms of exercise are being sug-
gested in the literature for people with MetS.18 In this sense,
whole-body vibration (WBV), which is a modality of exercise
involving mechanical vibration generated in oscillating/vibra-
tory platform, has been used as an alternative to manage indi-
viduals with different clinical disorders, including
fibromyalgia,19,20 cerebral palsy,21 and chronic obstructive
pulmonary disease.22 The WBV exercise can be considered a
feasible, safe, and low-cost technique to the improvement of
health in various populations.19-22 Biomechanical parameters,
such as the frequency and the peak-to-peak displacement of the
mechanical vibration, must be considered in the WBV exercise
protocols.23 Wei et al24 consider low frequency (20 Hz),
medium frequency (40 Hz), and high frequency (60 Hz).
The WBV exercise is associated with lower neuropathic
pain symptoms and acute and chronic reductions in pain levels
(PLs) measured in a visual analog pain scale (VAS).25 There is
also strong evidence of the effects of WBV on fitness, includ-
ing improvements in the flexibility of the lower limbs,26,27 that
could be justified by stretching of the muscles.28,29 It was sug-
gested that WBV would reduce the stiffness and hysteresis of
the tendon, alter the properties of the intramuscular connective
tissue,29 and possibly modify those of other passive skeletal
structures related to the range of motion for a determined
joint30 such as the knee.28 Acute and short- and long-term
effects of WBV exercise have been studied21,28,29,31 as well
as cardiovascular responses by WBV in young health
adults,32,33 older adults,34 and obese women.35
An increase in oxygen consumption (VO2) with minimal
cardiovascular stress (heart rate [HR], blood flow, or mean
arterial pressure) with the addition of WBV to a static semi-
squat exercise has been demonstrated. The findings could be
justified based on type or intensity of vibration.35
Di Giminiani et al36 showed that WBV acutely increased
lower back and hamstring flexibility and seems to be effective
on flexibility also in clinical populations,37,38 and this kind of
exercise could improve the quality of life that is poor in indi-
viduals with MetS.39,40 In fact, as reviewed by Sa´-Caputo
et al,26 WBV exercise could be suggested as a strategy to
improve flexibility in individuals with MetS. Beavers et al11
reported a poor physical performance in older adults with
MetS.
Considering the need and importance of physical activities,
the aim of the study was to assess the acute effect of WBV
exercise, with low frequency (5 Hz), on the (1) PL, (2) flexi-
bility, and (3) cardiovascular responses (BP and HR) in indi-
viduals with MetS. We hypothesized that 5 Hz WBV exposure
would be feasible, suitable, and safe and could significantly
favor better conditions to pain, flexibility, and cardiovascular
responses in individuals with MetS.
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Materials and Methods
As the entrance of the individuals to participate in this project
was not considering a specific randomization, the study is an
interventionist, cross-sectional, pseudo-randomized controlled
trial. In this sequence, they were allocated in the control or in
the WBV exercise groups.
In the current study, the problem was the unknown effect of
low-frequency (5 Hz) WBV on pain, flexibility, and cardiovas-
cular responses of individuals with MetS immediately after a
session of WBV and in a control group (individuals without
vibration exposition). This frequency (5 Hz) was previously
used in a work using WBV exercise in a case report of indi-
viduals with MetS26 and in a protocol involving individuals
with knee osteoarthritis.41
This study was approved by the Research Ethics Committee
of the Hospital Universita´rio Pedro Ernesto, Universidade do
Estado do Rio de Janeiro (HUPE/UERJ) with the number
CAAE 54981315.6.0000.5259.
Participants
Forty-nine participants with MetS were selected. Recruitment
and all the procedures were done from October 2013 to Decem-
ber 2015. The selection of the participants was made through a
screening performed by the medical staff of HUPE/UERJ. The
principles embodied in the Declaration of Helsinki were fol-
lowed. The authors confirm that all ongoing and related trials
for this intervention are registered. The registration was per-
formed following the guidelines of the Registro Brasileiro de
Ensaios Clı´nicos numbered RBR2bghmh.
The eligibility criteria were outpatient older than 40 years
with previous clinical diagnosis of MetS based on the criteria
described by the International Diabetes Federation.9 The exclu-
sion criteria were individuals with high BP (180  110 mm
Hg), cardiovascular disease (coronary artery disease or stroke),
and neurological, musculoskeletal, or rheumatologic disease
that do not permit perform WBV exercise. Those participants
who refused to sign the consent form for participation in the
study were also excluded.
The Transparent Reporting of Evaluations with Non-
randomized Designs statements42 were used to report all the
different steps of the interventions utilized in this study. The
dependent variables (pain, flexibility, BP, and HR) were mea-
sured before and after the WBV session (exercise group) or the
control session (control group).
Sample Size
For a statistical power of 95% and significance level of 5%, a
sample size (www.lee.dante.br/) of 13 participants was calcu-
lated, and the finding published by Vieira et al43 was consid-
ered. A sufficiently large sample size (n ¼ 49) was recruited to
account for potential dropout.
Allocation of the Participants
A convenience sample of 44 individuals was allocated in the
control group (n ¼ 15) or in the WBV exercise group (n ¼ 29)
in the sequence of the entrance of the participants in the study.
Outcomes
The PL, flexibility, and cardiovascular responses (BP and HR)
were evaluated in the control and WBV exercise groups before
and after the interventions. Anthropometric parameters (height
[m], waist circumference [cm], body mass [kg], body mass
index [kg/m2], and age [years]) were also verified before the
interventions.
Anthropometric Characteristics
The height and body mass were measured on a digital balance
(MIC 200 PPA, Micheletti, Sa˜o Paulo, Brazil). Then, the body
mass index was calculated by dividing the mass (kg) by the
height squared (m2). The baseline anthropometric data of the
participants of control and WBV groups were evaluated.
Pain Level
The PL was assessed using a VAS, with 10 indicating the
highest level of pain and 0 the lowest.25 The analyses were
performed in both groups before and after the intervention. In
all, 25 individuals of the WBV exercise group and 15 individ-
uals of the control group had pain before the interventions. The
individuals have reported that the pain was felt in parts of back
(lower back, cervical, and dorsal), lower (knee, heel, and hip),
and upper limbs (arm, shoulder, and fist).
Flexibility
The measure of the flexibility was performed through the ante-
rior trunk flexion (ATF) test also called fingertip-to-floor dis-
tance test.26 This test consisted of measuring the distance
between the tip of middle finger and the floor after an ATF,
with feet together and without bending the knees26,44 (Figure 1).
The distance between the third finger of the hand to the floor
and the measurements were performed once before and after
the procedures in both the groups.
Cardiovascular Responses (BP and HR)
An automated device (OMRON, model HEM-7113, China)
was utilized to record the systolic blood pressure (SBP) and
diastolic blood pressure (DBP; mm Hg), and the HR (beats/
min) was measured on the left arm of seated patient after a
10-minute rest.45 Three measurements were performed with
1 minute of rest after each measurement. Means of these
3 records of SBP and DBP and HR were used in the analyses
of the WBV exercise group and the control group. The mea-
surements were performed before and after the interventions in
both the groups.
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WBV exercise group Intervention
Patients were seated in a chair, in front of the platform, with
their bare feet on the base of the side alternating oscillating/
vibratory platform (Novaplate, Fitness Evolution, Sa˜o Paulo,
Brazil) with knees 50 flexed (from full extension of 180;
Figure 2A). The height of the chair was selected depending
on the height of the individual to have the same knee flexion.
The hands of the patient was positioned on the knees to facil-
itate the transmission of the mechanical vibration to the whole
body and to generate WBV exercise in the individual.
Participants performed the WBV exercise with low frequency
(5 Hz). Different peak-to-peak displacements were sequentially
used in 3 ways: (1) 2.5, (2) 5.0, and (3) 7 5 mm (Figure 2B). The
gravitational force was 0.12, 0.25, and 0.35 g, respectively, for
WBV. The session consisted of 9-minute bout of work inter-
spersed with 1-minute passive rest period between each bout.
The total time of intervention was 17 minutes.
Control Group Intervention
The patient performed the same position and time of the WBV
exercise group, but the side alternating oscillating/vibratory
platform was off and without mechanical vibration stimulus
transmission.
Statistical Analysis
The Shapiro-Wilk normality test was done to determine
whether the data set are well modeled by a normal distribution.
The Wilcoxon rank test was used to compare the results of HR,
BP, PL, and flexibility before and after each intervention
(WBV or control). These results are presented in mean and
standard error. The Mann-Whitney U test was used to compare
the anthropometric baseline data between WBV exercise group
and control group, and these results are presented as mean
(standard deviation). The level of significance was set at P <
.05. These analyses were executed using the GraphPad Prism 6
statistic program.
Results
A total of 49 participants were recruited, and 44 performed the
proposed intervention (15 in the Control Group and 29 in the
WBV exercise group). Side effects were not found in these
individuals during this study. The flow of participants through
each stage of the study is shown in Figure 3.
The anthropometric characteristics (baseline) of the individ-
uals in control and WBV exercise groups are presented in Table
1.
Considering the data analysis regarding the dependent vari-
ables, no significant difference was found between the 2 groups
as shown in Table 2.
All individuals completed the study, and the results before
and after the intervention are presented for all the outcomes
(PL, flexibility, and cardiovascular responses).
Considering the PL, the individuals of the WBV exercise
group presented a decrease in this parameter, with 2.28+ 0.65
before and 1.76 + 0.57 after the WBV exercise intervention
(P ¼ .03). In the Control Group, no significant change was
observed, with 2.61 + 0.67 before and 2.72 + 0.72 after the
intervention (P ¼ .75).
Figure 2. (A) Position of the individual during the interventions and
(B) side alternating oscillating/vibratory platform. It is indicated the
frequency (Hz), the peak-to-displacement (mm), and the acceleration
peak (g) used in the WBV exercise group. WBV indicates whole-
body vibration.
Figure 1. Individual performing the anterior trunk flexion test.
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A significant difference (P < .05) in ATF was found in WBV
exercise group, indicating an improvement on the flexibility of
these individuals. The value was 17.25 + 2.52 cm before and
15.15 + 2.36 cm after the intervention (P ¼ .004). In the
Control Group, no improvement in the flexibility was pre-
sented, and the data were 17.81 + 2.21 cm before and 16.84
Figure 3. Flow of participants through each stage of the study.
Table 1. The Baseline Anthropometric Characteristics of the Individ-
uals of Control Group and WBV Group.a
Control Group,
n ¼ 15, Mean (SD)
WBV exercise Group,
n ¼ 29, Mean (SD) P Value
Height,(m 1.61 (0.08) 1.63 (0.07) .74
WC, cm 108.3 (15.55) 103.0 (11.09) .32
Body mass, kg 87.43 (18.02) 83.65 (16.27) .70
BMI, kg/m2 32.79 (6.94) 31.16 (5.35) .55
Age, years 58.20 (9.11) 61.10 (8.39) .38
Abbreviations: BMI, body mass index; SD, standard deviation; WBV, whole-
body vibration; WC, waist circumference.
aP  .05.
Table 2. Data Analyses of Dependent Variables in the Baseline.
Control Group,
n ¼ 15, Mean (SD)
WBV exercise Group,
n ¼ 29, Mean (SD)
P
Value
Pain level (scale) 2.61 + 0.67 2.28 (0.65) .63
Flexibility, cm 17.81 (2.21) 17.25 (2.52) .43
SBP, mm Hg 121.3 (3.94) 129.0 (3.45) .97
DBP, mm Hg 65.65 (2.86) 68.57 (2.55) .27
Heart rate,
beats/min
67.29 (2.70) 70.29 (3.20) .63
Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure; SD,
standard deviation; WBV, whole-body vibration.
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+ 2.61 cm after the intervention (P ¼ .28). None of the parti-
cipants was able to reach the floor with the third finger.
Considering the cardiovascular responses, in the Control
Group, the findings of SBP were 121.3 + 3.94 mm Hg before
and 125.3+ 3.82 mm Hg after the intervention (P ¼ .06). The
data of DBP were 65.65 + 2.86 mm Hg before and 67.94 +
2.63 mm Hg after the intervention (P ¼ .08). In the WBV
exercise group, the SBP was 129.0 + 3.45 mm Hg before and
130.8 + 3.25 mm Hg after the WBV exercise (P ¼ .048). The
data of DBP was 68.57 + 2.55 mm Hg before and 68.48 +
2.42 mm Hg after the WBV exercise (P ¼ .92). The HR was
measured and found to be 67.29 + 2.70 beats/min before and
67.47 + 2.80 beats/min after the intervention (P ¼ .71) in the
control group. In the WBV exercise group, it was 70.29+ 3.20
beats/min before and 68.67 + 3.25 beats/min after the WBV
exercise (P ¼ .16). These parameters were not altered and are
presented in Figure 4A-D.
Discussion
The current study aimed to evaluate the effects of WBV on the
flexibility in individuals with MetS and to determine whether
these improvements are related to symptom severity (bodily
pain). The major findings of the study are that the WBV pro-
tocol applied with a low frequency (5 Hz) and that different
peak-to-peak displacement resulted in improvements, reducing
the PL and increasing flexibility. The results may be of clinical
importance, as WBV exercise could be considered as a safe and
reliable strategy in the management of individuals with MetS.
Moreover, this is a study that uses a simple and comfortable
position related to the WBV exercise to the management of
individuals with MetS.
Considering the relevance of exercises that could be suitable
and safe, and based on the analyses of the aforementioned
results about the cardiovascular responses, there were no sta-
tistically significant differences in SBP, DBP, and HR, before
and after the WBV exercise with 5 Hz in a side alternating
oscillating/vibratory platform. This is in agreement with the
findings reported by Robbins et al46 after WBV, although
they used 40 Hz in a synchronous platform in healthy
participants (12 males and 8 females). Figueroa et al47
suggested that WBV training with 25 to 30 Hz in a
synchronous platform may benefit arterial function in
deconditioned individuals who cannot perform conventional
exercise. The authors reported that 6 weeks of WBV training
decreased systemic arterial stiffness and SBP via
improvements in wave reflection and sympathovagal balance
in young overweight/obese normotensive women. Thus, it is
proposed that the WBV exercise may be used safely by
individuals with MetS without changes of the physiological
levels of arterial BP and HR.
As improvements in the flexibility are important for the
maintenance of the mobility and a better functional indepen-
dence, the flexibility was investigated in the current study.
Figure 4. (A) Blood pressure of control group, (B) blood pressure of whole-body vibration exercise group, (C) heart rate of control group, and
(D) heart rate of whole-body vibration exercise group. BP indicates blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure;
HR, heart rate.
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Chang et al13 have pointed out that flexibility should be
included in the complete evaluation for individuals with MetS.
Jacobs and Burns48 have suggested the application of WBV as
a preparatory activity before more intense exercise in untrained
individuals. Sa´-Caputo et al26 also found improvement on flex-
ibility in individuals with MetS after a similar protocol that was
used in the current study, although this is the unique study with
the investigated patient. Similarly, Rittweger35 suggested that
stretching could reduce the stiffness and hypothesize that these
changes could be due to alterations in (1) tendon, (2) properties
of the intramuscular connective tissue, and (3) passive skeletal
structures that together define the range of motion for a specific
joint.34 There is evidence in the literature suggesting that WBV
can improve flexibility in both trained and untrained partici-
pants,47 and previous studies have found that WBV can acutely
increase lower back and hamstring flexibility.36 These changes
were attributed to the activation of the Ia inhibitory interneur-
ons of the antagonist muscle after vibration. Another possible
explanation to these changes was reported by Cardinale and
Bosco49 who suggested that vibration may have caused
changes in intramuscular coordination, leading to a decrease
in the braking force around the hip and lower back joints, which
may also explain, at least in part, the improvements shown in
this study. In addition, an increase in the skin temperature and
blood flow could also partly justify the findings of this study37
because these physiological conditions could improve the
range of the motion of the joints.50
The current results may be related to a decrease in pain
sensation. Although the mechanisms underlying the association
between metabolic disturbances and pain would be complex,
the inflammation6 and the mechanical overload7 would be
associated with a reduction in chronic pain, especially in neu-
ropathic pain symptoms.25 As proposed by Kessler and Hong,25
it may be suggested that the mechanisms to justify the acute
pain effects would be related to vibration-induced sensory inhi-
bition at both the peripheral and the central levels. At the per-
ipheral level, a sensory inhibition would be linked to the gate
control theory of pain.51 According this theory, pain signals
need to encounter “neurological gates” at the spinal cord level
and are in charge of determining whether the pain signals
should reach the brain or not. In other words, pain is perceived
when the gate gives way to the pain signals, and it is less
intense or not at all perceived when the gate closes for the
signals to pass through. Thus, this may be the reason why WBV
is able to reduce the pain signal. Moreover, as postulated by
Longe et al,52 pain relief due the WBV would be linked to the
phenomenon related to the inhibition caused when the sensory
fibers type Ab conducting stimulus from specific mechanor-
eceptors, such as Pacinian and Meissner corpuscles. This phe-
nomenon would reduce the painful input of the type C fibers
by activating inhibitory circuits of the dorsal horn. At the
central level, the inhibition caused by vibration would be
justified by the proximity of areas responsible for processing
pain and vibrotactile sensations in the somatosensory cortices
of the brain.53 This may be of importance, since individuals
with MetS would have possibility in developing pain
conditions, and WBV could be suggested as a safe strategy
to decrease pain.
Despite promising results, the current study has some lim-
itations. It should be noted that the population of this work
consisted of outpatients with MetS. A relatively small number
of patients participated in the study, but it is higher than the
number needed that was calculated for the sample size. More-
over, the participants maintained the medication prescribed by
the physician during the interventions. In addition, only acute
effects are shown; however, these effects might relevant in the
rehabilitation of patients with MetS.
Conclusion
It is concluded that WBV exercise exposure with low fre-
quency (5 Hz) is responsible in inducing physiologic para-
meters that contribute to decrease the PL and to increase the
flexibility as well as to maintain cardiovascular responses (HR
and BP) in individuals with MetS. As a consequence, WBV
exercise may be considered as useful, feasible, and safe strat-
egy to be used on the management of individuals with MetS.
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